Did you know? · Science & Medicine

Perutz linked haemoglobin's shape to inherited disease

Max Perutz studied how changes in haemoglobin's amino acids alter its function, hoping to find drugs for genetic blood disorders such as sickle cell anaemia.

Max Perutz
Max Perutz · 1914–2002
Person
Max Perutz
Lived
1914–2002
Field
Molecular biology
From
Austrian-British

The story

Haemoglobin exists in many variant forms. Some are found in other species, such as crocodiles and carp, which have adapted their haemoglobin to unusual habitats and ways of life. Others are mutant human haemoglobins that cause inherited blood disorders. In 1957 Vernon Ingram, working in the same Cambridge unit as Max Perutz, discovered that sickle cell anaemia is caused by a single amino acid change in the haemoglobin molecule.

Once Perutz and his colleagues had solved haemoglobin's three-dimensional structure, he could see where each change sat in the molecule and explain its effect. Francis Crick, writing his obituary, recalled his strong interest in the consequences of amino acid differences, both in the many known human mutants and in other species, and noted that in most cases the change in the molecule's behaviour could be explained once the change in sequence was known. Perutz studied the structural changes behind a number of haemoglobin diseases and how they affect the binding of oxygen.

He hoped the molecule could be made to act as a drug receptor, and that it might become possible to inhibit or reverse the effects of genetic errors such as those behind sickle cell anaemia. He set out this approach in his 1992 book Protein Structure: New Approaches to Disease and Therapy.

In later years he worked on how small molecules bind to haemoglobin, aiming to develop a clinically useful drug that would increase oxygen delivery to oxygen-starved tumours to help radiation therapy, and to tissues damaged by heart attacks. He was still doing this kind of research in his eighties, working in the laboratory almost every day.

His approach of reading disease from a molecule's structure, and then looking for chemicals that fit it, anticipated the structure-based drug design used today. When he died in 2002 the head of the Medical Research Council said his prize-winning work on protein structure was more relevant than ever as scientists sought to understand the mechanisms of disease.

Why it matters

Perutz's work helped establish the idea of molecular disease and pointed the way to structure-based drugs for inherited disorders.

About Max Perutz

Viennese refugee who spent 22 years solving the structure of haemoglobin, won the 1962 Nobel Prize and built the Cambridge laboratory where molecular biology came of age.

Read the full profile
Max Perutz
1914–2002 · Molecular biology
View profile →

More about Max Perutz

Sources

Another act of tikkun olam. This is part of tikkun olam, the Jewish idea of repairing the world, and every one of us can add to it.

More in Science & Medicine

On kindness & the treatment of others
“A friend is devoted at all times; a brother is born to share adversity.”
Proverbs 17:17